Effect of Niacin on FGF23 Concentration in Chronic Kidney Disease

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Cardiovascular Effects of Sevelamer in Stage 3 CKD

(2013) C. D. Chue et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Prostaglandin D2 induces apoptosis of human osteoclasts by activating the CRTH2 receptor and the intrinsic apoptosis pathway

(2012) Li Yue et al.   BONE

Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals

(2012) Joachim H. Ix et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Phosphate Binders in Moderate CKD

(2012) G. A. Block et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Update on fibroblast growth factor 23 in chronic kidney disease

(2012) Myles Wolf   KIDNEY INTERNATIONAL

Phosphate and Cardiovascular Disease

(2011) Jessica Kendrick et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

(2011) Tamara Isakova   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Extended-release niacin/laropiprant lowers serum phosphorus concentrations in patients with type 2 diabetes

(2011) Andrew G. Bostom et al.   Journal of Clinical Lipidology

Elevated Fibroblast Growth Factor 23 is a Risk Factor for Kidney Transplant Loss and Mortality

(2011) M. Wolf et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients

(2011) E. Gonzalez-Parra et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Outcomes Associated With Phosphorus Binders in Men With Non–Dialysis-Dependent CKD

(2010) Csaba P. Kovesdy et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Binder Blinders—Niacin of Omission?

(2010) Andrew G. Bostom   AMERICAN JOURNAL OF KIDNEY DISEASES

Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk Predictions

(2010) Andrew S. Levey et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Once-Daily Extended-Release Niacin Lowers Serum Phosphorus Concentrations in Patients With Metabolic Syndrome Dyslipidemia

(2010) Susie Hu et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Hypophosphatemic Effect of Niacin in Patients without Renal Failure: A Randomized Trial

(2010) D. Maccubbin et al.   Clinical Journal of the American Society of Nephrology

Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community

(2010) Ravi Dhingra et al.   EUROPEAN JOURNAL OF HEART FAILURE

Forging Forward with 10 Burning Questions on FGF23 in Kidney Disease

(2010) M. Wolf   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease

(2010) T. Isakova et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Niacin as potential treatment for dyslipidemia and hyperphosphatemia associated with chronic renal failure: the need for clinical trials

(2010) Mohamed H. Ahmed   RENAL FAILURE

Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community

(2009) Majd A.I. Mirza et al.   ATHEROSCLEROSIS

Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease

(2009) Orlando M. Gutiérrez et al.   CIRCULATION

Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?

(2009) R. B. Oliveira et al.   Clinical Journal of the American Society of Nephrology

Effects of prostaglandin D2 on Na-dependent phosphate transport activity and its intracellular signaling mechanism in osteoblast-like cells

(2009) Shogo Asano et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: The Atherosclerosis Risk in Communities (ARIC) Study

(2008) Robert N. Foley et al.   AMERICAN HEART JOURNAL

A Randomized, Double-Blind, Placebo-Controlled Trial of Niacinamide for Reduction of Phosphorus in Hemodialysis Patients

(2008) S. C. Cheng et al.   Clinical Journal of the American Society of Nephrology

Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia

(2008) D. Maccubbin et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Prostaglandin D2 Receptors Control Osteoclastogenesis and the Activity of Human Osteoclasts

(2008) Marianne Durand et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

(2008) Orlando M. Gutiérrez et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Laropiprant on Nicotinic Acid-Induced Flushing in Patients With Dyslipidemia††A list of study investigators appears in the Appendix.

(2007) John F. Paolini et al.   AMERICAN JOURNAL OF CARDIOLOGY